近年来，生物制造已作为多数国家提升经济竞争力的着力点，也是我国继绿色制造、智能制造后，推进制造强国建设的又一重要抓手。同时，各地政府 地区通过结合自身优势力争实现合成生物"研发－转化－产业—集群"协同发展，发挥新质生产力 作用。 8月20-22日 将于 浙江·宁波 举 办 第四届合成生物与绿色生物制造大会 (简称： SynBioCon 2 025 ) 。大会 聚焦" 1+4 " ： AI+生 物智造 这一大热门赛道； 绿色化工与新材料、 未来食品、未来农业和美妆原料四大应用领域 ，邀请国 际领先企业、代表性产业化专家、政府、园 区、资本、协会和联盟等各方共探 "十五五"生物制造产业发展趋势 ； 哪些革新技术和产品将给生物制造产业带来持续的生命力 ； 并致力于 促进科技 成果转移转化 、 产品 规模 化与人才挖掘 。 一、组织机构 主办单位： 宁波德泰中研信息科技有限公司（ DT 新材料） 协办 单位： 宁波酶赛生物工程有限公司 二、大会亮点 三、大会日程 亮点一 ： 大会论坛、闭门活动洞察"十五五"生物制造发展趋势！探索新产品、新技术、新落地、 新合作！ 亮点二： 青年创新技术与价值分享、人才对接与合作！ 亮 ...

Core Viewpoint - The article emphasizes the development of the biomanufacturing industry in Hubei Province, which is seen as a key future industry as outlined in the 2025 government work report, aiming to transform small microorganisms into large-scale industries [1]. Group 1: Agricultural Biomanufacturing - Hubei Fubon Technology Co., Ltd. is focusing on innovative agricultural biopreparations, developing new biodegradable coating agents and soil restoration agents to enhance grain yield [2]. - The company's core product, "biostimulants," acts as a "lubricant" and "amplifier" in agricultural production, improving the efficiency of pesticides and fertilizers [4]. - The research team led by Professor Chen Shouwen from Hubei University has developed a biostimulant using Bacillus licheniformis, showcasing advantages in bioprocessing and broad applications [4]. Group 2: Industrial Microbial Strains - Industrial microbial strains are considered the "chips" of biomanufacturing, with over 80% of core industrial strains in China being dependent on foreign sources [6]. - Research on the strain "Pseudomonas putida" has shown its potential to convert agricultural waste into ethanol, presenting a sustainable alternative to traditional methods that rely on food crops [8]. - Wuhan Ruijia Kang Biotechnology Co., Ltd., founded by Professor Yang Shihui, has developed cellulose ethanol and D-lactic acid, with plans to achieve a production scale of 100,000 tons within five years [8]. Group 3: Collaborative Innovation - Hubei Province is building a collaborative system involving government, industry, academia, and finance to accelerate the development of biomanufacturing [9]. - Hubei University has established partnerships with companies like Angel Yeast to create a joint innovation platform for synthetic biology and modern biomanufacturing [10]. - The provincial government is addressing technology demands across various sectors to promote high-quality development in the synthetic biology industry during the 14th Five-Year Plan [12].

Core Points - The annual general meeting of Shanghai Cathay Biotech Co., Ltd. is scheduled for June 27, 2025, at 14:00, combining on-site and online voting methods [3][4] - The company reported a significant increase in revenue and net profit for 2024, with total revenue reaching CNY 2,957.91 million, a 39.91% increase year-on-year, and net profit attributable to shareholders amounting to CNY 488.96 million, a 33.41% increase [16][32] - The company plans to distribute a cash dividend of CNY 4.00 per 10 shares, totaling CNY 287.58 million, based on the audited net profit for 2024 [8][9] Meeting Procedures - Attendees must register and confirm their attendance before the meeting starts, and they are required to present their shareholder certificates to enter the venue [2][3] - The meeting will include the election of monitors and counters, the presentation of the independent directors' report, and the discussion of various proposals [4][6][11] Financial Performance - The company achieved a net profit of CNY 488.96 million in 2024, with a significant increase in net profit excluding non-recurring gains and losses, which rose by 51.60% to CNY 464.73 million [16][32] - The total assets of the company reached CNY 19.02 billion, reflecting a stable financial position [32] Strategic Developments - The company has successfully introduced CNY 5.915 billion in funding through a directed issuance of shares to enhance its business development [18] - A strategic cooperation agreement was signed with Hefei Municipal Government and China Merchants Innovation Technology Group to establish a synthetic biological materials industry cluster [18][28] Governance and Compliance - The board of directors and the supervisory board have actively fulfilled their responsibilities, ensuring compliance with relevant laws and regulations [19][25] - The company has maintained a high standard of information disclosure, achieving an A-level rating for its disclosure practices in the Shanghai Stock Exchange [23][26]

Core Insights - The Ministry of Industry and Information Technology and the National Development and Reform Commission have initiated a program to cultivate over 20 pilot platforms for biomanufacturing by 2027, aiming to facilitate industrial scale-up [1] - Significant technological breakthroughs and industrial layouts are emerging in the biomanufacturing sector, with advancements in areas such as polysulfone plastic recycling and wool sterol synthesis [1] - The synergy between policy support and industrial development is accelerating the transition of biomanufacturing from laboratory research to large-scale industrialization, showcasing a vibrant development chain of "technological breakthroughs - policy support - capital influx" [1] Industry Developments - Synthetic biology is reshaping production models in biomanufacturing, enabling tasks that traditional biotechnologies cannot achieve, while also providing more efficient and environmentally friendly biosynthesis solutions [1] - Companies like Huaxi Biological and Yikole are extending their capabilities in synthetic biology, with Huaxi focusing on the supply chain of hyaluronic acid and Yikole leveraging CRISPR-Cas9 technology for precise gene editing [2][3] - The integration of synthetic biology with traditional industries is seen as a means to enhance productivity and create new growth opportunities, rather than a conflict [4] Technological Innovations - Companies are developing comprehensive systems in synthetic biology, focusing on tool, platform, and product integration, with significant advancements in production efficiency [3] - AI is playing a crucial role in enhancing research efficiency in synthetic biology, with companies establishing AI teams to optimize data collection and algorithm development [7] - The use of AI in the design and testing phases of synthetic biology is expected to significantly reduce research timelines and costs, improving overall productivity [7] Market Trends - The biomanufacturing industry is experiencing a wave of policy support, with various local governments implementing initiatives to promote the industrialization of synthetic biology [8] - The market for biomanufacturing in China is projected to approach 1.8 trillion yuan by 2030, indicating substantial growth potential [8] - Recent financing trends show an acceleration in investments in domestic synthetic biology companies, with nearly a hundred firms securing new funding at the beginning of 2025 [8] Future Outlook - The synthetic biology sector is anticipated to undergo rapid technological iterations and deeper application expansions in the next 3-5 years, driven by AI advancements [9] - Companies are encouraged to focus on quality improvement and original design rather than mere scale expansion, to avoid resource wastage and industry chaos [9] - The industry is expected to face dual challenges in technology transfer and industrialization, particularly in constructing microbial cell factories and overcoming engineering challenges in fermentation and purification [10]

Group 1: Core Insights - The article introduces the "Global Bio-based Industry Monthly Report," providing insights into the latest trends and opportunities in the bio-based sector [1][2][3] - The report is available for free to industry peers, highlighting the importance of collaboration and information sharing within the bio-based industry [1][3] Group 2: Policy Releases - Three domestic bio-based related policies were recorded in May 2025, focusing on carbon reduction projects, including biodegradable polyester rubber and sustainable aviation fuel [7][8] - Key projects include a 110,000-ton biodegradable polyester rubber demonstration project and a 1 million-ton sustainable aviation fuel project [8] Group 3: Industry Dynamics - The report includes updates on domestic bio-based chemical companies, such as the establishment of a lactate production line with an investment of 120 million yuan [9][10] - New companies in the bio-based sector are emerging, such as Yantai Wanhua Chemical, which has launched a new subsidiary focused on food additives [10] Group 4: Capital Events - Several financing events in the bio-based sector were reported, including a B round financing of several million yuan for Senqi New Materials and angel round financing for Zhongke Kexin [11][22] - Notable investments include over 100 million yuan for a recombinant collagen company and nearly 100 million yuan for a bioactive ingredient company [22] Group 5: Scientific Research Progress - Significant breakthroughs in bio-based materials research were highlighted, including the development of a new type of conductive "E-skin" for health sensing applications [12][23] - Research on bioremediation using engineered bacteria to address complex organic pollutants was also reported, showcasing advancements in environmental applications of synthetic biology [23] Group 6: Upcoming Events - The Fourth Synthetic Biology and Green Bio-manufacturing Conference is scheduled for August 20-22, 2025, in Jinan, Shandong, focusing on the future of bio-manufacturing and technology transfer [25][26]

Core Viewpoint - Suzhou Yike Biotechnology Co., Ltd. is the world's first company to possess PCT patents for producing PHA biodegradable plastic resins, focusing on high-performance eco-friendly materials for food and medical packaging [1][3]. Group 1: Company Overview - Suzhou Yike Biotechnology Co., Ltd. held a project signing ceremony on June 12 and obtained its business license on the same day [1]. - The company aims to establish a research and development center and production base in Taihu New City, targeting an annual production capacity of 10,000 tons, with a phased construction plan [3]. Group 2: Market Potential - The global market for PHA microspheres and PHA bioplastics was valued at $18.8 million in 2023 and is projected to reach $36.7 million by 2030, with a compound annual growth rate (CAGR) of 10.1% from 2024 to 2030 [3]. - The top five global PHA manufacturers hold over 85% of the market share, indicating a concentrated industry [3]. Group 3: Industry Challenges - PHA materials have advantages in biodegradability and biocompatibility over traditional plastics, but their production costs remain higher, with raw material costs accounting for 60% of expenses [3]. - The ex-factory price of PHA products is approximately 40,000 yuan per ton, which limits industrial production and application [3]. Group 4: Future Outlook - The company plans to drive innovation in technology and aims to become a leading player in the bioplastics industry with a global presence [3]. - The industry is expected to see increased interest as more companies accelerate their efforts to develop low-cost raw materials and improve production efficiency [4].

Group 1: Policy Release - The report includes three domestic policies related to the bio-based industry released in May 2025, focusing on carbon reduction projects [7][18]. - Key projects include a 110,000-ton biodegradable polyester rubber demonstration project and a 1 million-ton waste oil processing sustainable aviation fuel project [8]. Group 2: Industry Dynamics - The report highlights two domestic bio-based chemical company updates, including a 120 million yuan investment in a lactic acid production demonstration line by Heilongjiang Guoke Bio-based New Materials [9]. - Wanhu Chemical has established a new company focusing on food additives, with a registered capital of 20 million yuan [10]. Group 3: Capital Events - Several financing events in the bio-based sector are reported, including a Series B round raising several million yuan for Senqi New Materials, focusing on bio-based high barrier film materials [11]. - Other notable investments include a multi-million yuan angel round for Zhongke Kexuan, specializing in fully natural degradable plastics [11]. Group 4: Scientific Research Progress - Significant breakthroughs in bio-based materials research are noted, including a study on lignin-derived carbon improving catalytic performance [12]. - Research on bio-inspired reconfigurable electronic skin has been developed, showcasing antibacterial properties for health sensing applications [12]. Group 5: Upcoming Events - The Fourth Synthetic Biology and Green Bio-manufacturing Conference will be held from August 20-22, 2025, in Jinan, Shandong, focusing on the development trends of the bio-manufacturing industry [25].

#全球政策进展 | 上海市 关于上海市2025年度关键技术研发计划"合成生物学"项目拟立项项目的公示 根据市科技计划项目管理办法有关规定，现将上海市2025年度关键技术研发计划"合成生物学"项目拟 立项项目予以公示。 | 图源：上海市科学技术委员会 | | --- | 公示链接：http://svc.stcsm.sh.gov.cn/public/guide 公示期：2025年6月12日至2025年6月18日 对公示内容持有异议的，请于公示期内以书面形式向我委反映。按照市科研失信行为调查处理办法有关 规定，个人提出异议的，请在异议材料上注明姓名和联系电话；单位提出异议的，请在异议材料上加盖 单位公章，并注明联系人和联系电话。我委对异议者的信息予以保密。为保证异议处理客观、公正、公 平，保护被公示者的合法权益，我委对匿名且无明确证据和可查线索的异议，不予受理。 材料寄送至：市科委科技人才处（上海市人民大道200号，邮编200003）。 投诉举报电话：60286858 业务咨询电话：8008205114（座机）、4008205114（手机） 上海市科学技术委员会 2025年6月12日 上海市2025年度关键技术研发 ...

Market Overview - On June 11, the A-share market experienced a rebound, with the ChiNext Index leading the gains. The Shanghai Composite Index closed at 3402.32, up by 0.52%, while the Shenzhen Component Index rose by 0.83% to 10246.02, and the ChiNext Index increased by 1.21% to 2061.87. The total trading volume in the Shanghai and Shenzhen markets was 1.26 trillion yuan, a decrease of 159.9 billion yuan compared to the previous trading day [2][3]. Sector Performance - The sectors that saw the most significant gains included rare earth permanent magnets, gaming, automotive parts, and securities. Conversely, sectors that experienced declines included controllable nuclear fusion, biological vaccines, communication services, and beverage manufacturing [2]. Automotive Industry Insights - According to the China Association of Automobile Manufacturers, in May 2025, China's automotive production and sales reached 2.649 million and 2.686 million units, respectively, with year-on-year growth of 11.6% and 11.2%. For the first five months of 2025, production and sales totaled 12.826 million and 12.748 million units, reflecting year-on-year increases of 12.7% and 10.9%. Notably, new energy vehicles accounted for 48.7% of total new car sales in May, with production and sales of 1.27 million and 1.307 million units, respectively, marking year-on-year growth of 35% and 36.9% [6]. International Market Overview - In the U.S. stock market on June 11, the three major indices saw slight declines. The Dow Jones Industrial Average closed at 42865.77, down by 1.10 points, while the S&P 500 fell by 16.57 points to 6022.24, a decrease of 0.27%. The Nasdaq Composite Index dropped by 99.11 points to 19615.88, down by 0.50%. In Europe, the FTSE 100 index rose by 11.27 points to 8864.35, while the CAC 40 index fell by 28.43 points to 7775.90, and the DAX index decreased by 38.66 points to 23948.90 [4][5]. Oil Market Update - On June 11, international oil prices saw a significant increase. The price of light crude oil futures for July delivery rose by $3.17 to $68.15 per barrel, a gain of 4.88%. Meanwhile, the August delivery of Brent crude oil futures increased by $2.90 to $69.77 per barrel, up by 4.34% [4][5]. U.S. Economic Indicators - The U.S. Consumer Price Index (CPI) for May showed a year-on-year increase of 2.4%, with a month-on-month rise of 0.1%. The core CPI, excluding volatile food and energy prices, also increased by 0.1% month-on-month and 2.8% year-on-year [7][8]. U.S.-China Trade Relations - The first meeting of the U.S.-China economic and trade consultation mechanism took place in London, where both sides engaged in in-depth discussions on trade issues. They reached a consensus on measures to implement the important agreements made during the recent phone call between the two countries' leaders [9][10]. Gaming Industry Developments - The gaming sector is set to benefit from strong policy support, with the Zhejiang provincial government implementing measures to promote international development in the gaming industry. Analysts predict that the revenue from Chinese games going abroad could grow at a compound annual growth rate (CAGR) of over 20%, potentially reaching $32.8 billion by 2025 [11][12].

Group 1: Policy Release - The report includes three domestic policies related to the bio-based industry released in May 2025, focusing on carbon reduction projects [7][18]. - Key projects include a 110,000-ton biodegradable polyester rubber demonstration project and a 1 million-ton waste oil processing sustainable aviation fuel project [8][19]. Group 2: Industry Dynamics - The report highlights two domestic bio-based chemical company updates, including a 120 million yuan investment in a lactic acid production demonstration line by Heilongjiang Guoke Bio-based New Materials [9][20]. - Wanhu Chemical has established a new company focusing on food additives, with a registered capital of 200 million yuan [10]. Group 3: Capital Events - Several financing events in the bio-based sector are reported, including a multi-million yuan investment in Senqi New Materials for bio-based high barrier film materials [11][22]. - Other notable investments include a joint investment exceeding 100 million yuan in Juyuan Bio for recombinant collagen [22]. Group 4: Scientific Research Progress - Significant breakthroughs in bio-based materials research are noted, including a study on lignin-derived carbon improving catalytic performance [12][23]. - Research on a new type of printable conductive "E-skin" with antibacterial properties has been developed, mimicking slime mold characteristics [12][23]. Group 5: Upcoming Events - The Fourth Synthetic Biology and Green Bio-manufacturing Conference will be held from August 20-22, 2025, in Jinan, Shandong, focusing on the development trends of the bio-manufacturing industry [25][26].